Goldman Sachs Group Inc

13F Holdings History for Silexion Therapeutics Corp - Ordinary shares, par value $0.0135 per share (SLXN)

Symbol: SLXN on Nasdaq
Investment type: Equity / Ordinary shares, par value $0.0135 per share
Latest Disclosed Ownership: 212K shares
Security Ownership: 2.4%

THE GOLDMAN SACHS GROUP, INC. ownership in Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN)

2025-05-13 - THE GOLDMAN SACHS GROUP, INC. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 212K shares of Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share (SLXN). This represents 2.4% percent ownership of the company. In their previous filing dated 2025-02-10, GOLDMAN SACHS GROUP INC had reported owning 112K shares, indicating an increase of 88.8% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
THE GOLDMAN SACHS GROUP, INC.	2.4%	-60%	$174K	212K	+99,703	+88.8%	$0.82	13G/A	3/31/2025	13 May 2025 11:36:32
THE GOLDMAN SACHS GROUP, INC.	6.6%		$92K	112K			$0.82	13G	12/31/2024	10 Feb 2025 17:31:22